Year: 2026

HERZLIYA, Israel, April 20, 2026 (GLOBE NEWSWIRE) — Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), a global commerce enablement, payments, and loyalty platform designed to help merchants scale their business, today announced its participation as both exhibitor and sponsor at the NAMA Show 2026 – the industry’s largest annual conference for vending and convenience service professionals – taking place April 22-24, 2026 in Los Angeles, CA. The NAMA Show is the premier gathering for unattended retail operators across North America. This year Nayax will be at Booth #1929 with a clear message: complexity in unattended retail can be turned into a strength with the right partner. Nayax delivers an integrated, end-to-end platform designed around how operators run their business. That means the freedom to deploy the right solution...

Partnership enables the integration of Turbo Energy’s AI-driven software into battery storage systems, supporting expansion of its high-margin international C&I pipelineHithium battery storage system powered by Turbo Energy’s AI-driven optimization platformHithium battery storage system powered by Turbo Energy’s AI-driven optimization platformHithium battery storage system powered by Turbo Energy’s AI-driven optimization platform VALENCIA, Spain, April 20, 2026 (GLOBE NEWSWIRE) — Turbo Energy, S.A. (Nasdaq: TURB) (“Turbo Energy” or the “Company”), a global integrator of AI-driven solar energy storage solutions and intelligent energy management systems, today announced strategic partnership with Hithium, a tier 1 global battery storage provider, to integrate its AI-driven optimization platform into Hithium’s battery...

Company Advances Next-generation Patented MDMA Toward Patient Dosing in 2026 TORONTO, April 20, 2026 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (CSE: MDMA)(OTCQB: MDXXF) (“PharmAla” or the “Company”), a global leader in the research, development and manufacturing of MDMA and next-generation MDXX class molecules, today responded to the Executive Order signed on April 18, 2026 by the President of the United States, which directs the U.S. Food and Drug Administration (“FDA”) and the U.S. Drug Enforcement Administration (“DEA”) to establish a pathway for eligible patients to access investigational psychedelic drugs, and directs the FDA Commissioner to issue National Priority Vouchers to appropriate psychedelic drugs that have received Breakthrough Therapy designation. Positioned...

NEW YORK and TORONTO, April 20, 2026 (GLOBE NEWSWIRE) — Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP), a clinical stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs”), today welcomed the White House Executive Order aimed at accelerating research, regulatory pathways, and patient access to psychedelic treatments. “The Executive Order reflects growing recognition of the urgent need for new treatment options in serious mental health conditions and the importance of advancing innovative therapies through rigorous, research-based development,” said Eric So, Interim Chief Executive Officer of Helus Pharma. “Policy momentum is meaningful, but the future of this field will ultimately be determined by the strength of the clinical evidence and the ability to deliver safe, reliable...

Howard’s nationwide reach across healthcare and public sector markets expands Nanox’s U.S. channel partner network to additional customer segments PETAH TIKVA, Israel, April 20, 2026 — Nano-X Imaging Ltd. (“Nanox”, or the “Company”, Nasdaq: NNOX), a leader in innovative medical imaging technology, today announced a strategic commercial agreement with Howard Technology Solutions, a leading U.S.-based technology solutions provider with deep expertise in healthcare and a broad national footprint. The agreement will support the commercial rollout of the Nanox.ARC, an FDA-cleared, multisource digital tomosynthesis system that makes 3D imaging possible in more clinical settings, at a lower cost and reduced radiation dose compared to traditional CT. Under the terms of the agreement, Howard Technology Solutions will market and deploy 300...

The strategic equity investment reflects a multiple of three times of Foresight’s current market value to reach a post investment valuation of approximately $35 million NESS ZIONA, Israel, April 20, 2026 (GLOBE NEWSWIRE) — Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in 3D perception systems, today announced that it has entered into a non-binding term sheet with VisionWave Holdings, Inc. (Nasdaq: VWAV) (“VisionWave”), a defense and advanced sensing technology company. Pursuant to the term sheet, at closing, VisionWave will make a strategic equity investment of up to $17.5 million (but not less than $15.45 million) through the issuance of VisionWave common stock based on the five-day average closing price of VisionWave’s common stock prior to closing. In exchange, VisionWave...

TORONTO, April 20, 2026 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2026 first quarter earnings conference call on Monday, May 11, 2026 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at https://ir.thecronosgroup.com/events-presentations. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast of the call will be archived for replay on the Company’s website. About Cronos Cronos is a global cannabis company focused on scaling leading consumer goods products through R&D and...

Marks Xtract One’s Fourth Canadian Provincial Health Authority Customer TORONTO, April 20, 2026 (GLOBE NEWSWIRE) — Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”) today announced its SmartGateway has been selected by Health PEI, the agency delivering publicly-funded health services on Prince Edward Island, to support its ongoing commitment to patient, staff, and visitor safety across its numerous facilities. The phased rollout deployment will enable Health PEI to continue delivering on its commitment to providing safe, quality health care to all Islanders in today’s modern threat environment. As the organization responsible for hospitals, healthcare centers, long-term nursing facilities, and community-based health programs throughout the province, Health PEI plays a central role in advancing...